Literature DB >> 25668377

The management of dental patients taking new generation oral anticoagulants.

Alun Scott1, John Gibson, Alexander Crighton.   

Abstract

Recently, new oral anticoagulants have been introduced as alternatives to warfarin. While national guidelines for treatment of dental patients taking warfarin as an anticoagulant are well-established, no such information is available for these novel therapeutic agents. At present, the local guidance available is contradictory between different health boards/health planning units, and liaison with the medical practitioner managing the individual patient's anticoagulation is imperative if any invasive procedure is proposed. This paper examines the available evidence regarding these drugs and sets out proposals for clinical guidance of dental practitioners treating these patients in primary dental care.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25668377     DOI: 10.1308/205016814813877289

Source DB:  PubMed          Journal:  Prim Dent J        ISSN: 2050-1684


  4 in total

1.  Postoperative bleeding risk for oral surgery under continued rivaroxaban anticoagulant therapy.

Authors:  Henning Hanken; Alexander Gröbe; Max Heiland; Ralf Smeets; Lan Kluwe; Johannes Wikner; Robert Koehnke; Ahmed Al-Dam; Wolfgang Eichhorn
Journal:  Clin Oral Investig       Date:  2015-10-26       Impact factor: 3.573

Review 2.  Dental management of patients taking novel oral anticoagulants (NOAs): Dabigatran.

Authors:  Adrian Curto; Alberto Albaladejo; Alfonso Alvarado
Journal:  J Clin Exp Dent       Date:  2017-02-01

Review 3.  Managing patients taking edoxaban in dentistry.

Authors:  Adrian Curto; Daniel Curto; Jorge Sanchez
Journal:  J Clin Exp Dent       Date:  2017-02-01

Review 4.  Latest Concepts in the Endodontic Management of Patients with Cardiovascular Disorders.

Authors:  Maryam Kuzekanani; James Leo Gutmann
Journal:  Eur Endod J       Date:  2019-04-24
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.